Royal Bank of Canada Portfolio holdings
Royal Bank of Canada (RBC), founded in 1864 and headquartered in Toronto, is Canada’s largest bank by market capitalization and one of the leading financial institutions in North America, offering a comprehensive suite of services including personal and commercial banking, wealth management, insurance, and capital markets. Managing hundreds of billions in assets, RBC serves millions of clients globally, with a significant presence in the U.S. and Caribbean through subsidiaries like RBC Wealth Management and City National Bank. Known for its stability and consistent profitability, RBC has earned a reputation as a conservative yet innovative bank, expanding its digital offerings and sustainability initiatives in recent years. With a strong focus on customer service and a robust international footprint, RBC remains a cornerstone of the Canadian and global financial systems.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Canadian Natural Resources
CNQ
|
+$1.33B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$985M |
| 3 |
Eli Lilly
LLY
|
+$901M |
| 4 |
Toronto Dominion Bank
TD
|
+$796M |
| 5 |
Blackrock
BLK
|
+$544M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HCA Healthcare
HCA
|
+$857M |
| 2 |
NVIDIA
NVDA
|
+$803M |
| 3 |
Vanguard S&P 500 ETF
VOO
|
+$676M |
| 4 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$671M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$611M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 19.21% |
| 2 | Technology | 15.76% |
| 3 | Industrials | 7.12% |
| 4 | Healthcare | 6.97% |
| 5 | Consumer Discretionary | 6.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4476
First Advantage
FA
$3.71B
| $238K | ﹤0.01% |
16,901
-3,381
| -17% | -$56.8K |
|
4477
JetBlue
JBLU
$2.13B
| $238K | ﹤0.01% |
49,347
-16,171,434
| -100% | -$106M |
|
4478
Ituran Location and Control
ITRN
$1.06B
| $237K | ﹤0.01% |
6,556
-1,461
| -18% | -$52.7K |
|
4479
Lineage Cell Therapeutics
LCTX
$271M
| $237K | ﹤0.01% |
528,656
+497,168
| +1,579% | +$292K |
|
4480
Lemonade
LMND
$4.07B
| $237K | ﹤0.01% |
7,557
-5,979
| -44% | -$206K |
|
4481
Organogenesis Holdings
ORGO
$230M
| $237K | ﹤0.01% |
54,839
-4,729
| -8% | -$19.1K |
|
4482
BlackRock TCP Capital
TCPC
$342M
| $237K | ﹤0.01% |
29,611
-7,761
| -21% | -$67.3K |
|
4483
Kodak
KODK
$979M
| $236K | ﹤0.01% |
37,261
-3,295
| -8% | -$22.9K |
|
|
LEO
4484
BNY Mellon Strategic Municipals
LEO
$390M
| $236K | ﹤0.01% |
38,500
| – | – |
|
|
PIM
4485
Franklin Master Intermediate Income Trust
PIM
$153M
| $236K | ﹤0.01% |
70,920
-12,656
| -15% | -$41.7K |
|
|
SBI
4486
Western Asset Intermediate Muni Fund
SBI
$108M
| $236K | ﹤0.01% |
30,278
+3,600
| +13% | +$28.2K |
|
|
BCIC
4487
BCP Investment Corp
BCIC
$94.7M
| $235K | ﹤0.01% |
16,354
+6,730
| +70% | +$111K |
|
4488
TMC The Metals Company
TMC
$1.77B
| $235K | ﹤0.01% |
136,708
-907
| -0.7% | -$1.52K |
|
4489
Marten Transport
MRTN
$1.24B
| $234K | ﹤0.01% |
17,028
+1,826
| +12% | +$27.2K |
|
4490
State Street SPDR Portfolio Europe ETF
SPEU
$743M
| $234K | ﹤0.01% |
5,325
+437
| +9% | +$18.9K |
|
4491
ARS Pharmaceuticals
SPRY
$562M
| $234K | ﹤0.01% |
18,547
+16,969
| +1,075% | +$204K |
|
4492
Consensus Cloud Solutions
CCSI
$716M
| $233K | ﹤0.01% |
10,109
-677
| -6% | -$17.4K |
|
4493
Fidus Investment
FDUS
$744M
| $233K | ﹤0.01% |
11,434
-2,574
| -18% | -$56.4K |
|
4494
INmune Bio
INMB
$60.2M
| $233K | ﹤0.01% |
29,863
+9,236
| +45% | +$73.3K |
|
4495
WisdomTree Europe SmallCap Dividend Fund
DFE
$170M
| $232K | ﹤0.01% |
3,798
+1,270
| +50% | +$75.2K |
|
4496
Dream Finders Homes
DFH
$1.42B
| $232K | ﹤0.01% |
10,275
+2,898
| +39% | +$67.7K |
|
4497
Embecta
EMBC
$289M
| $232K | ﹤0.01% |
18,201
+5,036
| +38% | +$80.6K |
|
4498
State Street Multi-Asset Real Return ETF
RLY
$1.31B
| $232K | ﹤0.01% |
8,131
+1,729
| +27% | +$48.4K |
|
4499
Princeton Bancorp
BPRN
$296M
| $231K | ﹤0.01% |
7,559
-298
| -4% | -$9.54K |
|
4500
iShares International Equity Factor ETF
INTF
$3.77B
| $231K | ﹤0.01% |
7,454
+1,619
| +28% | +$49.3K |
|
Similar funds
Royal Bank of Canada's Q1 2025 Portfolio in Review
As of Q1 2025, Royal Bank of Canada held 7,428 positions worth $479B, down 4.4% from $501B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Royal Bank of Canada's Q1 2025 filing shows 373 new, 3,020 increased, 3,038 reduced and 434 closed positions. Its largest new stake was Sandisk: 233,868 shares worth $11.1M. The largest sale was HCA Healthcare, an estimated $857M.
By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 18% a quarter earlier, followed by Technology and Industrials.
- Royal Bank of Canada's largest Q1 2025 buy was Sandisk: 233,868 shares worth $11.1M.
- Royal Bank of Canada added most to Canadian Natural Resources in Q1 2025, an estimated $1.33B increase.
- Royal Bank of Canada's biggest Q1 2025 reduction was HCA Healthcare, cutting an estimated $857M.
- Royal Bank of Canada fully exited Aspen Technology Inc in Q1 2025, selling an estimated $42.5M.
- Royal Bank of Canada's ten largest holdings make up 19% of its $479B portfolio in Q1 2025.
- Royal Bank of Canada opened 373 new positions and closed 434 in Q1 2025.
- Royal Bank of Canada's portfolio value fell 4.4% quarter-over-quarter to $479B.
Based on Royal Bank of Canada's 13F filing for Q1 2025, filed 15 May 2025.